Ardent Health Partners, LLC
ARDTNYSEHealthcare● Active
$8.57
$-0.11(-1.27%)
Market Cap$1.2B
P/E Ratio—
52W High$15.48
52W Low$7.71
Ardent Health Partners, LLC (ARDT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ARDT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.28
Est. $0.18 · +55.6%
Revenue
$1.60B
Est. $1.58B · +1.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue✓ 1-Quarter EPS Beat Streak
ARDT reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.24 | — | — | — | $1.65B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $0.18 | $0.28 | +55.6% | $1.60B | $1.58B | +1.5% |
| ▼ Q1 FY2026 | Mar 4, 2026 | $0.35 | $0.32 | -8.1% | $1.61B | $1.63B | -1.6% |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.42 | $0.52 | +22.6% | $1.58B | $1.55B | +1.8% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.30 | $0.52 | +73.3% | $1.65B | $1.63B | +0.7% |
| ▲ Q2 FY2025 | May 6, 2025 | $0.21 | $0.29 | +38.1% | $1.50B | $1.50B | -0.0% |
| ▲ Q1 FY2025 | Feb 26, 2025 | $0.50 | $0.81 | +62.0% | $1.61B | $1.50B | +7.3% |
| ▼ Q4 FY2024 | Nov 6, 2024 | $0.30 | $0.17 | -43.3% | $1.45B | $1.45B | -0.2% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.24
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.28
EPS Est.
$0.18
EPS Surpr.
+55.6%
Revenue
$1.60B
Q1 FY2026
Mar 4, 2026Miss
EPS Actual
$0.32
EPS Est.
$0.35
EPS Surpr.
-8.1%
Revenue
$1.61B
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.42
EPS Surpr.
+22.6%
Revenue
$1.58B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.52
EPS Est.
$0.30
EPS Surpr.
+73.3%
Revenue
$1.65B
Q2 FY2025
May 6, 2025Beat
EPS Actual
$0.29
EPS Est.
$0.21
EPS Surpr.
+38.1%
Revenue
$1.50B
Q1 FY2025
Feb 26, 2025Beat
EPS Actual
$0.81
EPS Est.
$0.50
EPS Surpr.
+62.0%
Revenue
$1.61B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
$0.17
EPS Est.
$0.30
EPS Surpr.
-43.3%
Revenue
$1.45B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.40 | $0.41 | $0.41 | 1 |
| Q3 FY2028 | $0.26 | $0.27 | $0.27 | 1 |
| Q2 FY2028 | $0.25 | $0.26 | $0.26 | 1 |
| Q1 FY2028 | $0.26 | $0.26 | $0.27 | 1 |
| Q4 FY2027 | $0.40 | $0.41 | $0.42 | 1 |
| Q3 FY2027 | $0.26 | $0.27 | $0.27 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.8B | $1.8B | $1.8B | 2 |
| Q3 FY2028 | $1.7B | $1.8B | $1.8B | 2 |
| Q2 FY2028 | $1.8B | $1.8B | $1.8B | 2 |
| Q1 FY2028 | $1.7B | $1.7B | $1.8B | 2 |
| Q4 FY2027 | $1.7B | $1.8B | $1.8B | 3 |
| Q3 FY2027 | $1.7B | $1.7B | $1.7B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +55.6% | $9.98 | $10.13 | +1.50% |
| ▼ Q1 FY2026 | Mar 4, 2026 | -8.1% | $9.41 | $9.64 | +2.44% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +22.6% | $14.05 | $14.05 | +0.00% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +73.3% | $10.31 | $10.65 | +3.30% |
| ▲ Q2 FY2025 | May 6, 2025 | +38.1% | $13.17 | $13.01 | -1.21% |
| ▲ Q1 FY2025 | Feb 26, 2025 | +62.0% | $14.45 | $14.01 | -3.04% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -43.3% | $18.05 | $16.27 | -9.86% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +13.3% | $16.01 | $16.00 | -0.06% |
Q2 FY2026+1.50%
Report Date
May 5, 2026
EPS Beat/Miss
+55.6%
Price Before
$9.98
Price After
$10.13
Q1 FY2026+2.44%
Report Date
Mar 4, 2026
EPS Beat/Miss
-8.1%
Price Before
$9.41
Price After
$9.64
Q4 FY2025+0.00%
Report Date
Nov 12, 2025
EPS Beat/Miss
+22.6%
Price Before
$14.05
Price After
$14.05
Q3 FY2025+3.30%
Report Date
Aug 5, 2025
EPS Beat/Miss
+73.3%
Price Before
$10.31
Price After
$10.65
Q2 FY2025-1.21%
Report Date
May 6, 2025
EPS Beat/Miss
+38.1%
Price Before
$13.17
Price After
$13.01
Q1 FY2025-3.04%
Report Date
Feb 26, 2025
EPS Beat/Miss
+62.0%
Price Before
$14.45
Price After
$14.01
Q4 FY2024-9.86%
Report Date
Nov 6, 2024
EPS Beat/Miss
-43.3%
Price Before
$18.05
Price After
$16.27
Q3 FY2024-0.06%
Report Date
Aug 14, 2024
EPS Beat/Miss
+13.3%
Price Before
$16.01
Price After
$16.00
Avg Beat Reaction+0.08%
Avg Miss Reaction-3.71%
Beat Rate6 / 8 quarters
Largest Move-9.86% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ARDT ends December
Ardent Health Partners, LLC (ARDT) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.28 — beating the analyst consensus of $0.18 by +55.6%. The next ARDT earnings date is expected around September 1, 2026.
Each quarter, investors track ARDT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ARDT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ARDT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ARDT earnings · 5 questionsArdent Health Partners, LLC's next earnings report is expected around September 1, 2026. ARDT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ARDT historically reports after market close (AMC).
ARDT earnings datewhen is ARDT earningsARDT next earnings datewhen does ARDT report earningsARDT earnings calendar
▸ Source: FMP · Ardent Health Partners, LLC SEC filings · US GAAP · Ardent Health Partners, LLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026